# Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

> **NCT06325423** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Muscle-Invasive Bladder Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT06325423
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04
- **Primary completion:** 2025-06
- **Final completion:** 2027-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325423, "Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06325423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*